Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
During live demonstrations, industry leaders highlighted SEOPRO’s ability to spot portfolio risk, execution bottlenecks, and decision delays early—before they escalate into costly program disruptions
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The move strengthens Sanofi’s presence in adult immunization by combining Dynavax’s innovative vaccines with Sanofi’s global scale and development capabilities
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
Subscribe To Our Newsletter & Stay Updated